Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir

• 主要な著者: Yin, Guosheng (著者), Zhang, Chenyang (著者), Jin, Huaqing (著者)
• フォーマット: 図書
• 出版事項: JMIR Publications, 2020-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

BackgroundRecently, three randomized clinical trials on coronavirus disease (COVID-19) treatments were completed: one for lopinavir-ritonavir and two for remdesivir. One trial reported that remdesivir was superior to placebo in shortening the time to recovery, while the other two showed no benefit o...